Drug intelligence / Profile preview

Closebax SD

Development stage
Unknown
Lead developer
Synchroline
Modality
Small Molecules
Administration
Topical
01

Overview

Closebax SD is a topical dermocosmetic product line developed by Synchroline (a brand of General Topics s.r.l.) specifically designed for the management of seborrheic dermatitis and severe dandruff. The formulation is available in various forms, including a shampoo and a cream, and utilizes a multi-targeted approach to address the underlying causes of seborrheic conditions. It typically contains a combination of antifungal agents such as **climbazole** and **piroctone olamine**, which inhibit the growth of *Malassezia* yeast, a primary contributor to seborrheic dermatitis. Additionally, it incorporates **triethyl citrate** to inhibit the lipase enzymes that break down sebum into irritating fatty acids, **zinc lactate** for sebum regulation, and **salicylic acid** for its keratolytic properties to facilitate the removal of scales and crusts. The product aims to reduce inflammation, itching, and desquamation while restoring the scalp's natural balance.

Brand names
Closebax SD
02

Targets

CYP51A1 (Sterol 14α-demethylase)GehA (Triacylglycerol lipase GehA)

Beyond the preview

Go deeper on Closebax SD.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Closebax SD.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call